Abstract:
Mutations in FOXL2 are known to cause autosomal dominant blepharophimosis-ptosis-epicanthus inversus syndrome (BPES), variably associated with premature ovarian failure. In this study we report results of mutational screening in a Czech and Slovak patient population with BPES.Case series.13 probands of Czech and 1 proband of Slovak origin with BPES and their available family members.Sanger sequencing and multiplex ligation-dependent probe amplification in 14 probands with BPES. Targeted mutational screening in first degree relatives.Genetic characterization and phenotype evaluation in Czech and Slovak individuals with BPES and their family members.Eight different mutations were detected including three novel ones; c.5 T > G; p.(Met2Arg), c.197C > A; p.(Ala66Glu) and c.701_702insTGCAGCCGCAGCGGCTGCAGCAGCTGCGGCTGCAGCCGC; p.(Ala222_Ala234dup). In one family, the molecular genetic cause of disease was not identified by the methodology used. In 13 pedigrees, a negative family history suggested a de novo origin, which could be confirmed by targeted mutational screening in four families. One 62- year-old female with the c.663_692dup30 mutation had an atypical phenotype presenting as moderate ptosis compensated by frontalis muscle contraction, no epicanthus inversus, and no premature ovarian failure.The de novo mutation rate in FOXL2 is exceptionally high compared to other dominant disorders manifesting with an ocular phenotype. In cases reporting a negative family history, careful examination of both parents is important to exclude mild features of the BPES phenotype.
